PRECISION NEUROSURGERY LTD

Company Registration Number:
14102193 (England and Wales)

Unaudited statutory accounts for the year ended 31 May 2023

Period of accounts

Start date: 11 May 2022

End date: 31 May 2023

PRECISION NEUROSURGERY LTD

Contents of the Financial Statements

for the Period Ended 31 May 2023

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8
Balance sheet notes - 11

PRECISION NEUROSURGERY LTD

Company Information

for the Period Ended 31 May 2023




Director: OLUWASEUN SOBOWALE
ALIX SOBOWALE
Registered office: 27
Maldon Drive
Eccles
Manchester
England
M30 9LU
Company Registration Number: 14102193 (England and Wales)

PRECISION NEUROSURGERY LTD

Directors' Report Period Ended 31 May 2023

The directors present their report with the financial statements of the company for the period ended 31 May 2023

Directors

The director(s) shown below were appointed to the company during the period
OLUWASEUN SOBOWALE
11 May 2022
ALIX SOBOWALE
11 May 2022

This report was approved by the board of directors on 5 February 2024
And Signed On Behalf Of The Board By:

Name: OLUWASEUN SOBOWALE
Status: Director

PRECISION NEUROSURGERY LTD

Profit and Loss Account

for the Period Ended 31 May 2023


Notes
13 months to
31 May 2023
£
Turnover 1,788
Cost of sales ( 2,177 )
Gross Profit or (Loss) ( 389 )
Distribution Costs ( 225 )
Operating Profit or (Loss) ( 614 )
Profit or (Loss) Before Tax ( 614 )
Profit or (Loss) for Period ( 614 )

The notes form part of these financial statements

PRECISION NEUROSURGERY LTD

Balance sheet

As at 31 May 2023


Notes
13 months to
31 May 2023
£
Fixed assets
Intangible assets: 4 10
Total fixed assets: 10
Current assets
Total assets less current liabilities: 10
Total net assets (liabilities): 10

The notes form part of these financial statements

PRECISION NEUROSURGERY LTD

Balance sheet continued

As at 31 May 2023


Notes
13 months to
31 May 2023
£
Capital and reserves
Called up share capital: 10
Shareholders funds: 10

For the year ending 31 May 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 5 February 2024
And Signed On Behalf Of The Board By:

Name: OLUWASEUN SOBOWALE
Status: Director

The notes form part of these financial statements

PRECISION NEUROSURGERY LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

PRECISION NEUROSURGERY LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

  • 2. Employees

    13 months to
    31 May 2023
    Average number of employees during the period 2

PRECISION NEUROSURGERY LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

  • 3. Off balance sheet disclosure

    No

PRECISION NEUROSURGERY LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

4. Intangible assets

Goodwill Total
Cost £ £
Additions 10 10
Disposals - -
Revaluations - -
Transfers - -
At 31 May 2023 10 10
Amortisation
Charge for year - -
On disposals - -
Other adjustments - -
Amortisation at 31 May 2023 - -
Net book value
Net book value at 31 May 2023 10 10

The company is in early stages of trading and as such, the value of the assets is low.